Semaglutide is administered as a once-weekly subcutaneous injection (marketed as Ozempic for diabetes and Wegovy for weight management) or as a daily oral tablet (Rybelsus)
Our staff at JosephCareRX is knowledgeable on the most recent developments in weight-loss treatments, including as GLP-1 receptor agonists, which were first created to treat type 2 diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] Bonaventura A, et al
These include: GLP-1 Daily Support : Designed to enhance the effects of GLP-1 therapy
The mean changes from baseline to week 26 were -2.2 kg, -3.1 kg and -0.6 kg in the RYBELSUS 7 mg, RYBELSUS 14 mg and sitagliptin 100 mg arms, respectively
For details about brand-name options, please consult your licensed healthcare provider or pharmacist